Celldex Therapeutics reported $-13481000 in EBITDA for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbvie ABBV:US $ 6136M 533M
Agenus AGEN:US $ -30.74M 0.74M
Amgen AMGN:US $ 2881M 473M
Aptinyx Inc APTX:US $ -11318000 10.06M
Bristol Myers Squibb BMY:US $ 3885M 729M
Celldex Therapeutics CLDX:US $ -13.48M 6.76M
Glaxosmithkline GSK:US $ 1818M 848M
Newlink Genetics NLNK:US $ -7.1M 0.46M
Pfizer PFE:US $ 2198M 1525M
Rigel Pharmaceuticals RIGL:US $ -13.62M 3.61M
Seattle Genetics SGEN:US $ 180.62M 473.02M